Compare FWONK & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FWONK | LH |
|---|---|---|
| Founded | 1950 | 1971 |
| Country | United States | United States |
| Employees | N/A | 70000 |
| Industry | Broadcasting | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9B | 25.9B |
| IPO Year | 2012 | 2005 |
| Metric | FWONK | LH |
|---|---|---|
| Price | $94.80 | $314.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 18 |
| Target Price | $119.29 | ★ $344.19 |
| AVG Volume (30 Days) | ★ 2.2M | 756.4K |
| Earning Date | 11-04-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 0.92% |
| EPS Growth | N/A | ★ 18.33 |
| EPS | 1.08 | ★ 6.99 |
| Revenue | $8,040,000,000.00 | ★ $13,951,700,000.00 |
| Revenue This Year | $21.63 | $5.72 |
| Revenue Next Year | $6.89 | $4.90 |
| P/E Ratio | $88.34 | ★ $44.37 |
| Revenue Growth | 5.87 | ★ 7.25 |
| 52 Week Low | $80.15 | $244.52 |
| 52 Week High | $107.31 | $341.80 |
| Indicator | FWONK | LH |
|---|---|---|
| Relative Strength Index (RSI) | 47.18 | 49.65 |
| Support Level | $94.10 | $304.29 |
| Resistance Level | $97.63 | $341.80 |
| Average True Range (ATR) | 2.47 | 6.17 |
| MACD | 0.26 | -0.24 |
| Stochastic Oscillator | 61.54 | 46.76 |
Liberty Media Corp along with its subsidiaries is engaged in the media and entertainment industries in North America and the United Kingdom. The company owns interests in a high-quality portfolio of assets across the media, entertainment and sports industries. It operates in two reportable segment Formula 1 and MotoGP. It generates majority of its revenue from the Formula 1 segment. The company derives its maximum revenue from United Kingdom.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.